Skip to content

Serum or Plasma Free Light Chain Immunoassay (Quantitative)

Published: August 9, 2026Updated: August 16, 2026

This test measures the levels of free light chains (kappa and lambda) in your blood, which are protein fragments produced by plasma cells. These fragments can help diagnose conditions affecting the immune system, blood cells, or kidneys.

Quick summary

["Light chains help detect hidden issues like multiple myeloma or kidney problems."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
90283-3
Short code
M tb DNA Bifl Ql NAA+probe
Synonyms
M tb DNA Bifl Ql NAA+probe
Category
chemistry
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
probe-amp-tar
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

Why This Test Matters

Free light chains are part of antibodies produced by plasma cells, which are white blood cells involved in fighting infections. When these cells become abnormal (e.g., in multiple myeloma or other blood disorders), they may release excess free light chains into the bloodstream. This test helps identify elevated levels that may signal underlying conditions requiring further evaluation.

How the Test Works

Your blood sample is analyzed using an immunoassay method to detect and quantify the specific free light chains (kappa and lambda). The results are reported separately for each type, though some labs may provide a combined ratio.

Sample Collection and Preparation

This test typically uses serum (blood without clotting factors) or plasma (blood with clotting factors). Your healthcare provider will collect a blood sample, usually from a vein in your arm, and send it to a lab for testing.

What to Expect Before the Test

No special preparation is usually needed, but you may be asked to avoid certain medications or foods that could interfere with results. If you have a history of bleeding disorders or are on blood thinners, let your provider know.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

◆Associated findings1

Short name

Free Light Chain Test

Frequently asked questions

What does an abnormal result mean?
Elevated free light chain levels (especially one type over the other) may indicate conditions like multiple myeloma, lymphoma, or other plasma cell disorders. Kidney disease can also cause elevated levels due to impaired filtering. Your doctor will review your results alongside other tests and symptoms to determine the next steps.
How are light chain tests used in diagnosis?
These tests are often used as part of a broader evaluation for blood disorders, such as checking for hidden myeloma or monitoring treatment response. They can also help assess kidney function indirectly by detecting abnormal protein fragments.
Can light chain tests be done at home?
No, this test requires a blood sample collected by a healthcare professional in a clinical setting. Results are typically reported within a few days and discussed with your doctor.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy